Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoflurane preconditioning in patients undergoing cardiac valve replacement
ChiCTR-TNRC-09000479Phase 4Completed
- Sponsor
- The Second Xiangya Hospital
- Start
- Apr 2008
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of isoflurane in Cardiac valve disease (VHD) (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoint: Genomics and proteomics. Started Apr 2008; status: completed.
02
Drugs
isoflurane
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR-TNRC-09000479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-09000479.